Product Details
Lamictal
Lamotrigine5 mg
Chewable Tablet
DIN/PIN/NPN
02240115
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
2023-04-28
Unit Price
0.2070
Amount MOH Pays
0.2070
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
N03AX09
Interchangeable Products
NOLU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Anticonvulsants | Lamotrigine (chewable)
For the adjunctive therapy for children over 2 years of age who are suffering from refractory seizures associated with Lennox-Gastaut syndrome, and who have previously tried other antiepileptic drugs. |